A new hormonal male contraceptive gel called Nestorone/Testosterone has shown promising results in reducing sperm count to levels low enough to prevent pregnancy.

The gel contains progestin and testosterone, which work by blocking testosterone production in the testes while maintaining a healthy sex drive.

Participants reported side effects including back acne, weight gain, and heightened sex drive, with minimal mood swings.

The gel has demonstrated 86% effectiveness in reducing sperm counts and is entering phase two clinical trials.

Alternative male contraceptive options being explored include a non-hormonal pill or gel injection.

Challenges in FDA approval and funding persist, with male contraception lacking financial support.

Further testing and funding are necessary before male contraception options can be widely accessible.

Dr. Wesley Baas emphasizes the potential benefits and safety measures of the gel.

Additional options like ADAM, a non-hormonal gel injection, are also being tested.